State of North Carolina and Biotech

Selected healthcare news for the location - State of North Carolina, and the healthcare topic - Biotech. We have 124 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
9/29/2021 MindMed Appoints Bryan Roth to Scientific Advisory Board NEW YORK, Sept. 29, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce the addition of Bryan L. Roth, MD, PhD to its Scientific Advisory Board. Dr. Roth has spent over 30 years studying molecular neuropharmacology. He is the Michael Hooker Distinguished Professor in the Department of Pharmacology at the University of North ...
9/20/2021 Bell Partners Acquires Newly Developed 272-Unit The Elliott Apartment Community in Raleigh-Durham Region of Chapel Hill ... ofNorth Carolina. BellChapel Hillis located inChapel Hill'sBlue Hill District and is positioned in the Research Triangle, one of the fastest growing metropolitan areas and employment centers in the country. Situated just off I-40, the property's location provides residents direct access to major employers including Apple's Future Campus, Google's Engineering Hub and numerous biotech and life science employers. BellChapel Hillis also proximate to leading research universities such asUniversity of North ...
9/16/2021 Aerie tries to wash over failure of midstage eye disease drug, but investors see right through it FierceBiotech Aerie Pharmaceuticals earned the ire of Bio Twitter and investors Wednesday night after dropping a failed midstage study after-hours, then whitewashing the flop and insisting a phase 3 would go ahead anyway.The phase 2b trial was testing the biotech's experimental AR-15512 (a TRPM8 agonist) ophthalmic solution in dry eye disease, a notoriously difficult eye condition to treat.Despite the Durham, North Carolina-based biotech reporting ‚Aupositive topline ...
9/10/2021 Bell Partners Acquires Newly Developed Multifamily Community in Chapel Hill, N.C. PR Newswire ... North Carolina .Bell Chapel Hill is located in Chapel Hill's Blue Hill District and is positioned in the Research Triangle, one of the fastest growing metropolitan areas and employment centers in the country. Situated just off I-40, the property's location provides residents direct access to major employers including Apple's Future Campus, Google's Engineering Hub and numerous biotech and life science employers. Bell Chapel Hill is also proximate to leading ...
9/10/2021 Bell Partners Acquires Newly Developed Multifamily Community in Chapel Hill, N.C. ... North Carolina. Bell Chapel Hill is located in Chapel Hill's Blue Hill District and is positioned in the Research Triangle, one of the fastest growing metropolitan areas and employment centers in the country. Situated just off I-40, the property's location provides residents direct access to major employers including Apple's Future Campus, Google's Engineering Hub and numerous biotech and life science employers. Bell Chapel Hill is also proximate to leading ...
9/8/2021 Moderna taps National Resilience's new Canadian manufacturing site for COVID-19 vaccine production duties | FiercePharma FiercePharma ... the plant will be delivered globally.The partnership marks Moderna‚Aos most recent foray into Canada and comes as the biotech faces a vaccine contamination scandal in Japan. In late August, Japanese pharma Takeda, which ... Sanofi biomanufacturing site and a former bluebird bio site in North Carolina ...
9/3/2021 Be a Genomics Landlord With One High-Growth Biotech REIT ... North Carolina. It was just west of what‚Aos known as the ‚AuResearch Triangle,‚Au an area of North Carolina that houses some of the country‚Aos most prestigious science and technology firms. Life comes full circle because now that small geographic area in North Carolina is becoming a biotech hotspot. A recent study from Newmark shows the Triangle is the fourth-largest life-science cluster in the U.S. It ...
9/1/2021 Medical Technologist - Clinical Laboratory Scientist - (Med Tech - MT - CLS) Job Details Company name Med Travelers Location Albemarle, NC, United States Employment Type Full-Time Industry Healthcare, Biotech, Clinical Research, Pharmaceutical, Scientist Posted on Aug 31, 2021 Valid Through Dec 14, 2021 Profile Job Description ... advanced cancer treatment, imaging, rehabilitation, and women\u2019s services in North Carolina. In addition to receiving the American Diabetes Association Recognition for Outpatient Diabetes Education, this hospital has also earned the Gold Seal of Approval ...
9/1/2021 Medical Laboratory Technician - (Med Lab Tech - MLT) Job Details Company name Med Travelers Location Albemarle, NC, United States Employment Type Full-Time Industry Healthcare, Biotech, Clinical Research, Pharmaceutical, Bluecollar, Sciences Posted on Aug 31, 2021 Valid Through Dec 14, 2021 Profile Job ... advanced cancer treatment, imaging, rehabilitation, and women\u2019s services in North Carolina. In addition to receiving the American Diabetes Association Recognition for Outpatient Diabetes Education, this hospital has also earned the Gold Seal of Approval ...
8/31/2021 Army Vet Parlays College, Military Experiences into Her Dream Job … in Biotech ... Biotech In early 2020, Diane Zambrano landed what she thought would be her dream job as a flight attendant with Delta Air Lines. After a seven-year stint in the Army the Ridgefield, New Jersey native moved to Raeford, N.C. in early 2011 and opened a dog training business. Nearly seven more years later, seeking more challenge, Zambrano then enrolled in the University of North Carolina at Pembroke, earning a ...
8/26/2021 Crain's Life Sciences forum tackles challenges and triumphs of growing sector Crain's New York Business New Yorkers hate to think of their city as second to anywhere, but when it comes to the life sciences sector, the Big Apple has ranked in the back of the pack, behind the Bay Area, the Research Triangle in North Carolina and (shudder) Boston. ‚AuNew York City has the second-largest academic biotech medical infrastructure and funding in the United States, behind only Boston,‚Au said Dr. Robert Lifton ...
8/19/2021 $300K Grant Opens New Durham Tech Biotech Aseptic Training Program 300K Grant Opens New Durham Tech Biotech Aseptic Training Program Federal and local grants totaling $300,000 are enabling a new pharmaceutical manufacturing workforce training program at Durham Technical Community College. Elected representatives, business and industry leaders, and workforce developers joined U.S. Rep. David Price at the North Carolina Biotechnology Center for the announcement this morning. Price, Chair of the Durham County Commissioners Brenda Howerton, and Durham Tech President J.B. Buxton ...
8/16/2021 BioAgilytix to Purchase Australia-based 360biolabs(R) ... development capabilities and geographiesBioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed ... GCLP) in Melbourne, Victoria with BioAgilytix's existing laboratories in Durham, North Carolina; Boston, Massachusetts; and Hamburg, Germany.Located in Australia's biomedical and clinical research hub, 360biolabs offers world-class virology and immunology expertise, with BSL ...
8/16/2021 BioAgilytix to Purchase Australia-based 360biolabs® Yahoo News ... Aug. 16, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed ... GCLP) in Melbourne , Victoria with BioAgilytix's existing laboratories in Durham, North Carolina ; Boston, Massachusetts ; and Hamburg, Germany .360biolabs® is the leading and most comprehensive specialty laboratory in the Australia & New Zealand region. Located in ...
8/16/2021 BioAgilytix to Purchase Australia-based 360biolabs® PR Newswire DURHAM, N.C. BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed a definitive ... GCLP) in Melbourne , Victoria with BioAgilytix's existing laboratories in Durham, North Carolina ; Boston, Massachusetts ; and Hamburg, Germany .360biolabs® is the leading and most comprehensive specialty laboratory in the Australia & New Zealand region. Located in ...
8/16/2021 BioAgilytix to Purchase Australia-based 360biolabs¬Æ ... 16, 2021 /PRNewswire/ ‚Ai BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed ... in Melbourne, Victoria with BioAgilytix‚Aos existing laboratories in Durham, North Carolina; Boston, Massachusetts; and Hamburg, Germany. 360biolabs¬Æ is the leading and most comprehensive specialty laboratory in the Australia & New Zealand region. Located in ...
8/16/2021 BioAgilytix to Purchase Australia-based 360biolabs¬Æ - Samachar Live ... 16, 2021 /PRNewswire/ ‚Ai BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed ... in Melbourne , Victoria with BioAgilytix‚Aos existing laboratories in Durham, North Carolina ; Boston, Massachusetts ; and Hamburg, Germany .Located in Australia‚Aos biomedical and clinical research hub, 360biolabs offers world-class virology and immunology expertise, with ...
8/16/2021 BioAgilytix to Purchase Australia-based 360biolabs¬Æ ... 16, 2021 /PRNewswire/ ‚Ai BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed ... in Melbourne , Victoria with BioAgilytix‚Aos existing laboratories in Durham, North Carolina ; Boston, Massachusetts ; and Hamburg, Germany . 360biolabs¬Æ is the leading and most comprehensive specialty laboratory in the Australia & New Zealand region.Located in ...
8/16/2021 BioAgilytix to Purchase Australia-based 360biolabs® ... Aug. 16, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed ... GCLP) in Melbourne, Victoria with BioAgilytix's existing laboratories in Durham, North Carolina; Boston, Massachusetts; and Hamburg, Germany. Located in Australia's biomedical and clinical research hub, 360biolabs offers world-class virology and immunology expertise, with BSL ...
8/16/2021 BioAgilytix to Purchase Australia-based 360biolabs® ... Aug. 16, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed ... GCLP) in Melbourne , Victoria with BioAgilytix's existing laboratories in Durham, North Carolina ; Boston, Massachusetts ; and Hamburg, Germany . 360biolabs® is the leading and most comprehensive specialty laboratory in the Australia & New Zealand region.Located in ...
8/16/2021 BioAgilytix to Purchase Australia-based 360biolabs¬Æ ... August 16, 2021 ‚Ai BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed ... in Melbourne, Victoria with BioAgilytix‚Aos existing laboratories in Durham, North Carolina; Boston, Massachusetts; and Hamburg, Germany. Located in Australia‚Aos biomedical and clinical research hub, 360biolabs offers world-class virology and immunology expertise, with ...
8/9/2021 PharmaVoice Honors Two NC Execs Among 100 ‚ÄòMost Inspiring Leaders‚Äô PharmaVoice Honors Two NC Execs Among 100 ‚AoMost Inspiring Leaders‚Ao Two North Carolina-based executives are among the 100 most inspiring leaders in the nation‚Aos pharmaceutical industry, according to the life sciences magazine ... Corporate Communications functions. In 2020, she led the company‚Aos Biotech and Enterprise Commercial teams to record new business growth. Howell has more than 25 years of leadership experience in the healthcare industry, and prior ...
8/4/2021 Global Biotech Leader Amgen Chooses Holly Springs for New Manufacturing Facility Amgen, one of the world's leading biotechnology companies, announced plans today to invest $550 million to build a new manufacturing facility in Holly Springs, North Carolina. The investment will bring 355 jobs to Holly Springs, which has become a preferred destination for the life sciences industry. "With Amgen's reputation as one of the founding companies of the biotech revolution, it is a welcome addition to Wake County's robust biotechnology sector ...
8/3/2021 Economic development roundup: $550M investment to create 355 biotech jobs in North Carolina Biotech company Amgen will invest $550 million to build a biologics manufacturing operation in Holly Springs, company and North Carolina officials announced Tuesday. The investment is expected to create 355 jobs in Wake County. The facility will include a biologics drug substance manufacturing plant to help Amgen meet the production demands for its medicines. ‚AuAmgen is investing in a technologically-advanced drug substance plant in North Carolina to support the ...
5/30/2021 Leading Cell Therapy Biotech Company Chooses Research Triangle for Its North American R&D and Manufacturing Facility Press Release: Raleigh, N.C. CARsgen Therapeutics Corporation, an innovative biotechnology company pursuing medicines to treat cancer will create approximately 200 jobs and invest $157 million in Durham, Governor Roy Cooper announced today. The company's selection of the Research Triangle area will establish its first biomanufacturing site in North America. CARsgen Therapeutics currently has its U.S. clinical development operations in Houston, Texas. "Global companies know that North Carolina is a world ...